# Fangyuan Capital

> Fangyuan Capital is a VC fund backing Medical, Manufacturing and Pharmaceutical. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 5
- Last investment: Dec 2024
- Lead investor: 20%
- Last updated: Aug 2026

Fangyuan Capital is an investment firm

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 40% |
| Manufacturing | 2 | 40% |
| Pharmaceutical | 2 | 40% |
| Biopharma | 1 | 20% |
| Electronics | 1 | 20% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 20% |
| Series A | 1 | 20% |
| Series B | 1 | 20% |
| Series C | 1 | 20% |
| Series D | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Baoji Pharmaceutical | Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. |  | Series C | Dec 01, 2024 |  |
| Weidu Technology | Weidu Technology offers goods such as fully redundant wire-control chassis, powertrain, body design, and interior. |  | Series A | Jun 02, 2023 |  |
| Beijing Weilan New Energy Technology | Beijing Weilan New Energy Technology Co., Ltd. is a high-tech enterprise focusing on the development and production of next-generation all-solid-state batteries. One of the battery companies with patents and technologies for all solid-state battery cores. With the core concept of “Huijuwei Blue, Leading Solid State”, the company has a leadingdomestic and international leading technology and development team. | $208.8M | Series D | Nov 04, 2022 |  |
| META Pharmaceuticals | META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases. | $15M | Seed | Jun 13, 2022 |  |
| Just Medical | Just Medical is an artificial orthopedic implant device and system developer. | $34M | Series B | May 06, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [Bureau Capital,](https://shizune.co/investors/profile/bureau-capital) — VC Fund, 1 deal together
- [Center Ventures](https://shizune.co/investors/profile/center-ventures) — VC Fund, 1 deal together
- [Chengtong Mixed Reform](https://shizune.co/investors/profile/chengtong-mixed-reform) — VC Fund, 1 deal together
- [China Merchants Venture Capital](https://shizune.co/investors/profile/china-merchants-capital) — VC Fund, 1 deal together
- [CITIC Construction Investment](https://shizune.co/investors/profile/citic-construction-investment) — VC Fund, 1 deal together
- [Dinghang Capital](https://shizune.co/investors/profile/dinghang-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Fangyuan Capital invest in?

Fangyuan Capital invests primarily in Medical, Manufacturing and Pharmaceutical startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Fangyuan Capital last invest?

The most recent investment recorded for Fangyuan Capital closed in Dec 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co